| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| R B Lindert, C G Haase, U Brehm, C Linington, H Wekerle, R Hohlfel. Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein. Brain : a journal of neurology. vol 122 ( Pt 11). 1999-12-10. PMID:10545394. |
multiple sclerosis: b- and t-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein. |
1999-12-10 |
2023-08-12 |
human |
| M Rodriguez, C F Lucchinett. Is apoptotic death of the oligodendrocyte a critical event in the pathogenesis of multiple sclerosis? Neurology. vol 53. issue 8. 1999-11-30. PMID:10563600. |
is apoptotic death of the oligodendrocyte a critical event in the pathogenesis of multiple sclerosis? |
1999-11-30 |
2023-08-12 |
Not clear |
| I Plo, S Ghandour, A C Feutz, M Clanet, G Laurent, A Bettaie. Involvement of de novo ceramide biosynthesis in lymphotoxin-induced oligodendrocyte death. Neuroreport. vol 10. issue 11. 1999-09-30. PMID:10439466. |
both experimental and clinical studies suggest that lymphotoxin (lt) plays an important role in multiple sclerosis (ms) by inducing oligodendrocyte (ol) depletion. |
1999-09-30 |
2023-08-12 |
mouse |
| M W Craighead, P Tiwari, R G Keynes, C M Water. Human oligodendroglial cell line, MO3.13, can be protected from apoptosis using the general caspase inhibitor zVAD-FMK. Journal of neuroscience research. vol 57. issue 2. 1999-07-28. PMID:10398301. |
recent evidence suggests that the oligodendrocyte cell loss observed in multiple sclerosis sufferers is in part mediated by apoptosis. |
1999-07-28 |
2023-08-12 |
human |
| A Stefferl, U Brehm, M Storch, D Lambracht-Washington, C Bourquin, K Wonigeit, H Lassmann, C Liningto. Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the "resistant" Brown Norway rat: disease susceptibility is determined by MHC and MHC-linked effects on the B cell response. Journal of immunology (Baltimore, Md. : 1950). vol 163. issue 1. 1999-07-15. PMID:10384097. |
experimental autoimmune encephalomyelitis (eae) induced by active immunization with the myelin oligodendrocyte glycoprotein (mog) is an ab-mediated, t cell-dependent autoimmune disease that replicates the inflammatory demyelinating pathology of multiple sclerosis. |
1999-07-15 |
2023-08-12 |
rat |
| S Mazzucco, S Matà, M Vergelli, R Fioresi, E Nardi, B Mazzanti, M Chelli, F Lolli, M Ginanneschi, F Pinto, L Massacesi, A M Papin. A synthetic glycopeptide of human myelin oligodendrocyte glycoprotein to detect antibody responses in multiple sclerosis and other neurological diseases. Bioorganic & medicinal chemistry letters. vol 9. issue 2. 1999-05-11. PMID:10021921. |
a synthetic glycopeptide of human myelin oligodendrocyte glycoprotein to detect antibody responses in multiple sclerosis and other neurological diseases. |
1999-05-11 |
2023-08-12 |
human |
| N J Scolding, P J Rayner, D A Compsto. Identification of A2B5-positive putative oligodendrocyte progenitor cells and A2B5-positive astrocytes in adult human white matter. Neuroscience. vol 89. issue 1. 1999-04-26. PMID:10051212. |
in the light of the rodent data showing the importance of oligodendrocyte progenitors in myelin repair, our findings suggesting the presence of progenitors in the adult human brain may have significant implications for spontaneous remyelination in multiple sclerosis and other demyelinating conditions. |
1999-04-26 |
2023-08-12 |
human |
| A Karni, R Bakimer-Kleiner, O Abramsky, A Ben-Nu. Elevated levels of antibody to myelin oligodendrocyte glycoprotein is not specific for patients with multiple sclerosis. Archives of neurology. vol 56. issue 3. 1999-04-14. PMID:10190821. |
elevated levels of antibody to myelin oligodendrocyte glycoprotein is not specific for patients with multiple sclerosis. |
1999-04-14 |
2023-08-12 |
Not clear |
| A Karni, R Bakimer-Kleiner, O Abramsky, A Ben-Nu. Elevated levels of antibody to myelin oligodendrocyte glycoprotein is not specific for patients with multiple sclerosis. Archives of neurology. vol 56. issue 3. 1999-04-14. PMID:10190821. |
to evaluate the presence and specificity of anti-myelin oligodendrocyte glycoprotein (mog) antibody in the cerebrospinal fluid and plasma of patients with multiple sclerosis (ms). |
1999-04-14 |
2023-08-12 |
Not clear |
| M Ichikawa, C S Koh, Y Inaba, C Seki, A Inoue, M Itoh, Y Ishihara, C C Bernard, A Komiyam. IgG subclass switching is associated with the severity of experimental autoimmune encephalomyelitis induced with myelin oligodendrocyte glycoprotein peptide in NOD mice. Cellular immunology. vol 191. issue 2. 1999-03-15. PMID:9973531. |
we have recently shown that a single dose of the myelin oligodendrocyte glycoprotein (mog) peptide 35-55 produces a relapsing-remitting demyelinating disease similar to multiple sclerosis (ms) in lewis rats. |
1999-03-15 |
2023-08-12 |
mouse |
| G Wolswij. Oligodendrocyte regeneration in the adult rodent CNS and the failure of this process in multiple sclerosis. Progress in brain research. vol 117. 1999-03-11. PMID:9932412. |
oligodendrocyte regeneration in the adult rodent cns and the failure of this process in multiple sclerosis. |
1999-03-11 |
2023-08-12 |
Not clear |
| M K Storch, A Stefferl, U Brehm, R Weissert, E Wallström, M Kerschensteiner, T Olsson, C Linington, H Lassman. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain pathology (Zurich, Switzerland). vol 8. issue 4. 1999-01-29. PMID:9804377. |
autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. |
1999-01-29 |
2023-08-12 |
rat |
| N Scolding, R Franklin, S Stevens, C H Heldin, A Compston, J Newcomb. Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis. Brain : a journal of neurology. vol 121 ( Pt 12). 1999-01-22. PMID:9874475. |
oligodendrocyte progenitors are present in the normal adult human cns and in the lesions of multiple sclerosis. |
1999-01-22 |
2023-08-12 |
human |
| A Slavin, C Ewing, J Liu, M Ichikawa, J Slavin, C C Bernar. Induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein. Autoimmunity. vol 28. issue 2. 1998-12-29. PMID:9771980. |
myelin oligodendrocyte glycoprotein (mog) is postulated to be a target autoantigen in multiple sclerosis (ms). |
1998-12-29 |
2023-08-12 |
mouse |
| E Wallström, M Khademi, M Andersson, R Weissert, C Linington, T Olsso. Increased reactivity to myelin oligodendrocyte glycoprotein peptides and epitope mapping in HLA DR2(15)+ multiple sclerosis. European journal of immunology. vol 28. issue 10. 1998-12-15. PMID:9808202. |
increased reactivity to myelin oligodendrocyte glycoprotein peptides and epitope mapping in hla dr2(15)+ multiple sclerosis. |
1998-12-15 |
2023-08-12 |
Not clear |
| P Hjelmström, A E Juedes, J Fjell, N H Ruddl. B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization. Journal of immunology (Baltimore, Md. : 1950). vol 161. issue 9. 1998-11-18. PMID:9794370. |
myelin oligodendrocyte glycoprotein (mog) induced experimental allergic encephalomyelitis (eae) is an animal model for the central nervous system disease multiple sclerosis (ms). |
1998-11-18 |
2023-08-12 |
mouse |
| N K de Rosbo, A Ben-Nu. T-cell responses to myelin antigens in multiple sclerosis; relevance of the predominant autoimmune reactivity to myelin oligodendrocyte glycoprotein. Journal of autoimmunity. vol 11. issue 4. 1998-11-05. PMID:9776706. |
t-cell responses to myelin antigens in multiple sclerosis; relevance of the predominant autoimmune reactivity to myelin oligodendrocyte glycoprotein. |
1998-11-05 |
2023-08-12 |
Not clear |
| N Benjelloun, A Ménard, C Charriaut-Marlangue, K Mokhtari, H Perron, J J Hauw, F Riege. Case report: DNA fragmentation in glial cells in a cerebral biopsy from a multiple sclerosis patient. Cellular and molecular biology (Noisy-le-Grand, France). vol 44. issue 4. 1998-10-20. PMID:9678892. |
multiple sclerosis is characterized by myelin destruction and oligodendrocyte loss. |
1998-10-20 |
2023-08-12 |
Not clear |
| C Mertens, D Brassat, J Reboul, S Eichenbaum-Voline, C Vuillemin-Azais, I Cournu, M C Babron, G Semana, G Edan, M Clanet, F Clerget-Darpoux, A Baron-Van Evercooren, O Lyon-Caen, R Liblau, B Fontain. A systematic study of oligodendrocyte growth factors as candidates for genetic susceptibility to MS. French Multiple Sclerosis Genetics Group. Neurology. vol 51. issue 3. 1998-10-20. PMID:9748021. |
a systematic study of oligodendrocyte growth factors as candidates for genetic susceptibility to ms. french multiple sclerosis genetics group. |
1998-10-20 |
2023-08-12 |
Not clear |
| K Akassoglou, J Bauer, G Kassiotis, M Pasparakis, H Lassmann, G Kollias, L Prober. Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy. The American journal of pathology. vol 153. issue 3. 1998-09-24. PMID:9736029. |
oligodendrocyte apoptosis and primary demyelination induced by local tnf/p55tnf receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy. |
1998-09-24 |
2023-08-12 |
mouse |